Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

Publications

Drug Information Group faculty regularly publish articles on a variety of topics in peer-reviewed journals and other educational formats.

Recent Publications (2015 - Present)

  • Ipema HJ, Maslennikov E, Munir F, Hartke P, et al. Actionable renal dosing content for nephrotoxic medications in 4 drug information resources commonly used in the United States. J Pharm Pract. Published online July 28, 2025.
  • Munir F. Optimizing Pharmacotherapy In Chronic GVHD.Pharmacy Practice News. June 2025. Available at:
    https://www.pharmacypracticenews.com/Clinical/Article/06-25/Chronic-Graft-Versus-Host-Disease-Management/77436.
  • Hellenbart EL, Rodriguez-Ziccardi MC, Ipema HJ, Krishna H, DiDomenico RJ. Disease-modifying therapies for amyloid transthyretin cardiomyopathy: a review of current and emerging medications. Pharmacotherapy. 2025:45(2):124-144.
  • Phillips J. Ch 1. How to be a great student: strategies for effective learning. In: Bachenheimer B, Phillips J, eds. Manual for Pharmacy Technicians. 7thBethesda, MD: American Society of Health-System Pharmacists; 2025.
  • Phillips J, Ipema HJ. Ch 19. In the real world. In: Bachenheimer BS, Phillips J, eds. Manual for Pharmacy Technicians. 7th Bethesda, MD: American Society of Health-System Pharmacists; 2025.
  • Wasynczuk J. Approved pharmacological interventions for sleep, anxiety, and depression: a monograph of mechanisms and safety profiles. In: Cundell DR, Bower AH, eds. Tackling the Sleep Quality, Anxiety and Depression Crisis Exacerbated During COVID: Current Pharmaceutical Strategies Compared to Phytomedicine Alternatives. Nova Science Publishers, Inc; 2025:149-223.
  • Fydrych J, Ipema H, Munir F, Koppen L. Survey of drug information, literature evaluation, and biostatistics curricula among US colleges of pharmacy. Curr Pharm Teach Learn. 2025;17(3):102270.
  • Shultz B, Mucksavage J, Goliak K,Phillips J, Thambi M. Investigating the perceptions and behaviors that contribute to student preparation for the NAPLEX exam. Curr Pharm Teach Learn. 2025;17(2):102228.
  • Gustafson KA, Berman S, Gavaza P, Mohamed I, Devraj R, Abdel Aziz MH, Singh D, Southwood R, Ogunsanya ME, Chu A, Dave V, Prudencio J, Munir F, et al. Pharmacy faculty and students perceptions of artificial intelligence: a national survey. Curr Pharm Teach Learn. 2025;17(6):102344.
  • Ipema HJ, Denton CD, Joseph H, Koppen L, Munir F, et al. Drugs to be used with a filter for preparation and/or administration – 2024. Hosp Pharm. 2025;60(4):390-398.
  • Munir F, Abdulbaki E, Saiyad Z, Ipema H. Taking the plunge together: a student-led faculty learning seminar series on artificial intelligence. Curr Pharm Teach Learn. 2025;17(8):102370.
  • Munir F, Ipema H, Nohria R, Singh D. Pharmacy meets AI: effect of a drug information activity on student perceptions of generative artificial intelligence. Curr Pharm Teach Learn. 2025;17(10):102439.
  • Gustafson KA, Rowe C, Gavaza P, Bernknopf A, Nogid A, Hoffman A, Jones E, Showman L, Miller V, Abdel Aziz MH, Brand-Eubanks D, Do DP, Berman S, Chu A, David V, Devraj R, Hintze TD, Munir F, et al. Pharmacists’ perceptions of artificial intelligence: A national survey. J Am Pharm Assoc (2003). 2025;65(1):102306.
  • Abdulbaki E, Saiyad Z, Phillips J, Munir F. Current summary of AI policies and statements in healthcare. KeePosted. 2024;50(4):23-25.
  • Elste JM. Rheumatoid Arthritis Symptom Control: Insights and Interventions for Pharmacy Practice. Specialty Pharmacy Continuum. December 2024. Available at:
    https://www.specialtypharmacycontinuum.com/Online-First/Article/12-24/Rheumatoid-Arthritis-Symptom-Control-Insights-and-Interventions-for-Pharmacy-Practice/75749.
  •  Koppen L. Biosimilars: Expanding Options for Inflammatory Disease Treatment. Pharmacy Practice News. November 2024. Available at:
    https://www.pharmacypracticenews.com/Clinical/Biosimilars/Article/11-24/Biosimilar-Treatment-Inflammatory-Diseases/75397.
  • Ipema HJ, Joseph H. A History of Pharmacy as a Profession, Part 2 (Looking Forward). Pharmacy Practice News. November 2024. Available at: https://www.pharmacypracticenews.com/Operations-and-Management/Article/11-24/A-History-of-Pharmacy-as-a-Profession/75416.
  • Joseph H, Ipema HJ. A History of Pharmacy as a Profession, Part 1 (Looking Back). Pharmacy Practice News. October 2024. Available at: https://www.pharmacypracticenews.com/Clinical/Article/10-24/A-History-of-Pharmacy-as-a-Profession/75032.
  • Elste JM, Phillips J. A Summary of Selected 2023-2024 FDA MedWatch Alerts. Pharmacy Practice News. September 2024. Available at: https://www.pharmacypracticenews.com/Clinical/Article/09-24/A-Summary-of-Selected-2023-2024-FDA-MedWatch-Alerts/74748.
  • Johnson ST, Goldwire MA, Abdalla M, Advani A, Alhammad AM, Anderson KC, Bernknopf A, Blommel ML, Brunner R, Frazier J, Gor P, Gosser R, Ipema H, Kier KL, Kostrzewa A, Majerczyk D, Manian R, Maxwell E, May D, May JR, Munir F, Okafar I, Phillips J, et al. Teaching learners to identify and reduce the spread of medical misinformation. J Am Coll Clin Pharm. 2024;7(9):926-940.
  • Harris IM, Hilaire ML, Jeon M, Kier KL, Munir F, et al. Pharmacists’ role in combating medical misinformation. J Am Coll Clin Pharm. 2024;7(9):947-951.
  • Johnson ST, Goldwire MA, Abdalla M, Al-Shehre WH, Bernknopf A, Colella A, Denton C, Douglas JS, Gosser R, Heindel G, Holsopple M, Ipema H, Kier K, Kostrzewa A, Majerczyk D, May D, May JR, Mersek ST, Munir F, et al. PRN Opinion Paper | Drug Information: From Education to Practice – 2024 Update – an opinion paper of the Drug Information Practice and Research Network of the American College of Clinical Pharmacy. J Am Coll Clin Pharm. 2024;7(5):492-504.
  • Krueger C, Syeda A. Overview of Long-Acting Injectable Schizophrenia Medication. Pharmacy Practice News. June 2024. Available at:
    https://www.pharmacypracticenews.com/Clinical/Article/06-24/Overview-of-Long-Acting-Injectable-Schizophrenia-Medications/74012
  • Munir F, Gehres A, Wai D, Song L. Evaluation of ChatGPT as a tool for answering clinical questions in pharmacy practice. J Pharm Pract. 2024;37(6):1303-1310.
  • Rodriguez R, Joseph H, Macrito R, Lee TA, Sweiss K. Risk prediction models for antineoplastic-associated cardiotoxicity in treatment of breast cancer: A systematic review. Am J Health Syst Pharm. 2023;80(19):1315-1325.
  • Sarna K, Phillips J. The Pharmacist’s Role in Ensuring Safe and Effective Use of Approved Cannabis Therapies. Pharmacy Practice News. November 2023. Available at: https://www.pharmacypracticenews.com/Clinical/Article/11-23/The-Pharmacists-Role-in-Ensuring-Safe-and-Effective-Use-Of-Approved-Cannabis-Therapies/71910.
  • Koppen L. Advances in Pharmacotherapy for Narcolepsy and Idiopathic Hypersomnia. Pharmacy Practice News. December 2023. Available at:
    https://www.pharmacypracticenews.com/Clinical/Article/12-23/Advances-in-Pharmacotherapy-for-Narcolepsy-and-Idiopathic-Hypersomnia/72280.
  • Griggs L, Phillips J. Drug allergy practice parameter update: focus on antibiotics. KeePosted. 2023;49(3):26-29.
  • Adebogun O, Phillips J. The pharmacist’s role in applying the updated Beers Criteria. KeePosted. 2023;49(4):30-32.
  • Phillips J. Medical misinformation: the power of influence. J Am Coll Clin Pharm. 2023;6(5):444-445.
  • Elste J, Ipema H, Denton C, Munir F, et al. Light-sensitive injectable prescription drugs – 2022. Hosp Pharm. 2023;58(5):448-475.
  • Ipema HJ, Elste J, Koppen L, Soni R, et al. Inclusion of optimal guidelines for pharmacists in UpToDate. Ann Pharmacother. 2022;56(9):1084-1085.
  • Rodriguez R, Brunner R, Spencer S, et al. Time to inclusion in clinical guidance documents for non-oncological orphan drugs and biologics with expedited FDA designations: a retrospective survival analysis. BMJ Open. 2021;11(12):e057744.
  • Brunner R, Gerberich A. Managing Pain in Parkinson’s Disease. Practical Pain Management. 2021;21(1). Available at:
    https://www.practicalpainmanagement.com/treatments/pharmacological/managing-pain-parkinson-disease.
  • Gerberich A, Ipema HJ. A primer on ocular viscosurgical devices. Am J Health Syst Pharm. 2021;78(22):2020-2032.
  • Joseph H, Gabay M. CDC Opioid Prescribing Guideline: Clinical Concerns Lead to Revision. Practical Pain Management. 2021;21(6). Available at:
    https://www.practicalpainmanagement.com/treatments/pharmacological/opioids/cdc-opioid-prescribing-guideline-clinical-concerns-lead-revision.
  • West-Thielke PM, Ipema HJ, Campbell-Lee S, et al. Removal of anti-thymocyte globulin by plasma exchange in ABO-incompatible and positive crossmatch kidney transplant recipients. Transplant Proc. 2021;53(5):1548-1553.
  • Bursua A, Mudreac A, Koppen L, Larson C, Park YS, Sreedhar R. Effect of default order standardization on opioid prescribing patterns. Jt Comm J Qual Patient Saf. 2021;47(7):431-437.
  • Ipema H, Zacher J, Galka E, Nazari J, Varabyeva A, Yu M, Hartke P. Drugs to be used with a filter for preparation and/or administration-2019. Hosp Pharm. 2021;56(2):81-87.
  • Sarna K. Best practices for monitoring hazardous drug surface contamination: a guidance for health care institutions. Pharmacy Practice News. July 2020. Available at:
    https://www.pharmacypracticenews.com/Review-Articles/Article/07-20/Best-Practices-for-Monitoring-Hazardous-Drug-Surface-Contamination/58875.
  • Sarna K. Hyperkalemia management: role of the pharmacist in optimization of care. Pharmacy Practice News. March 2020. Available at:
    https://www.pharmacypracticenews.com/Clinical/Article/03-20/Hyperkalemia-Management/57443.
  • Nathan J, Grossman S, Ness G, Gabay M, Ipema H, Tierno H. Update on the status of drug information centers in the United States. Am J Health Syst Pharm. 2020;77(1):33-38.
  • Sarna KV, Griffin T, Tarlov E, et al.  Trends in gender composition on editorial boards in leading medicine nursing, and pharmacy journals.  J Am Pharm Assoc. 2020;60(4):565-570.
  • Spencer SH, Menard SM, Labedz MZ, Krueger CD, Sarna KV. Enteral tube administration of oral chemotherapy drugs. J Oncol Pharm Pract. 2020;26(3):703-717.
  • Miles K, Zacher J. A physician primer: drugs with orphan designations for the treatment of pain conditions. Practical Pain Management. 2019. Available at:
    https://www.practicalpainmanagement.com/resources/practice-management/physician-primer-drugs-orphan-designations-treatment-pain-conditions?fbclid=IwAR00bFHTLtzYJvpnDRYaDA4H1TZC0Gota6X1Zf1pNmui04XB-POuOmBIaVg.
  • Gerberich A, Spencer S, Ipema H. National Guideline Clearinghouse is no more – keep calm and search on. Ann Pharmacother.2019;53(4):434-436.
  • Rodriguez R, Koppen L, Patel YA, Ellinger, LK. Characteristics of shortage-related drug information requests and recommendations from a nationally-serving drug information center.Am J Health Syst Pharm. 2019;76(23):1900-1902.
  • Sarna KV, Gross AE. Vancomycin versus metronidazole for non-severe Clostridioides difficile infection: are the data adequate to change practice? Ann Pharmacother. 2019;53(8):845-852.
  • Rasmussen JT, Ipema HJ. Formulary considerations for insulins approved through the 505(b)(2) ‘follow-on’ pathway. Ann Pharmacother. 2019;53(2):204-210.
  • Koppen L, Suda K, Rowan S, McGregor J, Evans C. Dentists’ prescribing of antibiotics and opioids to Medicare Part D beneficiaries: medications of high impact to public health. J Am Dent Assoc. 2018;149(8):721-730.
  • Spencer S, Ipema H, Hartke P, Krueger C, et al. Intravenous push administration for antibiotics: An alternative method. Hosp Pharm. 2018;53(3):157-169.
  • Koppen L, Whitaker A, Rosene A, Beckett R. Effect of berberine alone and in combination for the treatment of hyperlipidemia: a systematic review. J Evid Based Complementary Altern Med. 2017;22(4):956-968.
  • Rodriguez R, Soni R. Psoriatic arthritis: established, newer, and emerging therapies. Practical Pain Management. 2017;17(6). Available at:
    https://www.practicalpainmanagement.com/pain/myofascial/inflammatory-arthritis/psoriatic-arthritis-established-newer-emerging-therapies.
  • Koppen L, Afanasjeva J. A brief history of the FDA’s role in the ongoing effort to ensure safe opioid use. Practical Pain Management. 2017;17(1). Available at:
    https://www.practicalpainmanagement.com/treatments/pharmacological/opioids/brief-history-fda-role-ongoing-effort-ensure-safe-opioid-use.
  • Bursua A, Hartke PL, Larson CM. Benchmarking and medication error rates. Am J Health Syst Pharm. 2016;73(11):744.
  • Hartke P, Afanasjeva J. Sports-related pain: topical treatments. Practical Pain Management. 2016;16(4). Available at:
    http://www.practicalpainmanagement.com/treatments/pharmacological/non-opioids/sports-related-pain-topical-treatments.
  • Zych K, Ipema H. Psoriasis and psoriatic arthritis: update in management. Specialty Pharmacy Continuum. January/February 2016. Available at:
    http://www.specialtypharmacycontinuum.com/download/psoriasis_spc0116_WM.pdf.
  • Hartke PL, Vermeulen LC, Hoffman JM, et al. Accuracy of prescription drug expenditure forecasts published in the AJHP. Am J Health Syst Pharm. 2015;72(19):1642-1648.
  • Koppen L, Phillips J, Papageorgiou R. Analysis of reference sources used in drug-related Wikipedia articles. J Med Libr Assoc. 2015;103(3):140-144.
  • Ghaibi S, Ipema HJ, Gabay MG. ASHP guideline on the pharmacist’s role in providing drug information. Am J Health Syst Pharm. 2015;72(7):573-577.
  • Ipema HJ, Tanzi MG. Medical writing and peer review. In: Gabay M, ed. The Clinical Practice of Drug Information. 1st Sudbury, MA: Jones & Bartlett Learning; 2015.